Pfizer
Developing innovative healthcare therapies
- B2B
- B2C
- Has physical offices
- Publicly traded
- Manufacturing
- Multi-product
- Sales-led purchase
About Pfizer
A leading biopharmaceutical company focused on research and innovation to develop therapies that improve and extend the lives of patients worldwide
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- new york, United States
- Revenue
- $62.6BFY2025, publicly reported
- Website
- pfizer.com
- linkedin.com/company/pfizer
Pfizer competitors
Jobs at Pfizer
- Senior Manager Corporate Governance & Company Secretary
- Director, Commercial Data & Analytics Architecture
- Senior Director, Quality Management Systems
- Senior Associate, Senior Data Manager, Clinical Data Sciences
- Director, Global Fetrastobart Vedotin
- Specialty Care Patient Engagement Go-To-Market Excellence Director
- Global Hospital & Biosimilars Health & Science Specialist (SHSS) - Upstate NY
- GL Data & System Care Manager - Chennai
Pfizer in the news
- No, Pfizer CEO did not say it planned to halve the world’s population
A viral video misrepresented Pfizer CEO's statement about reducing the number of people who cannot afford medicines.
- Should FDA Approval of Updated COVID Vaccine for Vulnerable Groups Prompt a Closer Look at Pfizer (PFE)?
FDA approved Pfizer's updated COVID vaccine for vulnerable groups, extending its COVID relevance but with limited impact on overall revenue amid ongoing oncology growth and regulatory risks.
- Mixed options sentiment in Pfizer with shares up 0.63%
Pfizer's shares rose modestly with light options trading, lower implied volatility, and increased demand for downside protection.
- Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now
Pfizer's stock is an underrated dividend investment due to its sustainable high yield, low valuation, and extensive drug pipeline, despite recent underperformance and restructuring challenges.
- Vaxcyte rises as pneumococcal shot establishes ‘new competitive moat’ vs. Pfizer, Merck
Vaxcyte's VAX-31 pneumococcal vaccine achieved strong Phase 3 trial results, outperforming Pfizer's Prevnar 20 and Merck's Capvaxive on certain serotypes, indicating significant market potential.
Pfizer at a glance
Pfizer is a B2B/B2C company in the Pharmaceutical Manufacturing industry, headquartered in new york, United States.
Pfizer has 10,000+ employees.
Pfizer's revenue is $62.6B (FY2025, publicly reported).
Pfizer is hiring: 8 recent open roles, including Senior Manager Corporate Governance & Company Secretary, Director, Commercial Data & Analytics Architecture, Senior Director, Quality Management Systems.
Selling to companies like Pfizer?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies